TY  - JOUR
AU  - Perez, Antonio
AU  - Carrasco-Sánchez, Francisco Javier
AU  - González, Carlos
AU  - Seguí-Ripoll, José Miguel
AU  - Trescolí, Carlos
AU  - Ena, Javier
AU  - Borrell, Mireia
AU  - Gomez Huelgas, Ricardo
PY  - 2020
DO  - 10.1136/bmjdrc-2020-001518
UR  - http://hdl.handle.net/10668/16256
T2  - BMJ open diabetes research & care
AB  - This study assessed the efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in insufficiently controlled people with type 2 diabetes. COBALTA (for its acronym in Spanish, COntrol...
LA  - en
KW  - blood Glucose
KW  - diabetes mellitus
KW  - hypoglycemia
KW  - insulin glargine
KW  - type 2
KW  - Aftercare
KW  - Blood Glucose
KW  - Diabetes Mellitus, Type 2
KW  - Hospitalization
KW  - Humans
KW  - Insulin Glargine
KW  - Patient Discharge
TI  - Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial.
TY  - research article
VL  - 8
ER  -